BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Noris M, Remuzzi G. Hemolytic uremic syndrome. J Am Soc Nephrol. 2005;16:1035-1050. [PMID: 15728781 DOI: 10.1681/asn.2004100861] [Cited by in Crossref: 333] [Cited by in F6Publishing: 108] [Article Influence: 19.6] [Reference Citation Analysis]
Number Citing Articles
1 D'Alessio L, Pinto A, Cangelosi A, Geoghegan PA, Tironi-Farinati C, Brener GJ, Goldstein J. Sub-Lethal Dose of Shiga Toxin 2 from Enterohemorrhagic Escherichia coli Affects Balance and Cerebellar Cytoarchitecture. Front Microbiol 2016;7:133. [PMID: 26904009 DOI: 10.3389/fmicb.2016.00133] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
2 Abu Daher G, Aoun B, Jaafar F, Khafaja S, Sanjad S. Norovirus: a novel etiologic agent in hemolytic uremic syndrome in an infant. BMC Nephrol 2019;20:247. [PMID: 31277594 DOI: 10.1186/s12882-019-1427-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
3 Costin M, Cinteza E, Balgradean M. Hemolytic Uremic Syndrome - Case report. Maedica (Bucur) 2019;14:298-300. [PMID: 31798749 DOI: 10.26574/maedica.2019.14.3.298] [Reference Citation Analysis]
4 Qin J, Cui Y, Zhao X, Rohde H, Liang T, Wolters M, Li D, Belmar Campos C, Christner M, Song Y, Yang R. Identification of the Shiga toxin-producing Escherichia coli O104:H4 strain responsible for a food poisoning outbreak in Germany by PCR. J Clin Microbiol 2011;49:3439-40. [PMID: 21752971 DOI: 10.1128/JCM.01312-11] [Cited by in Crossref: 32] [Cited by in F6Publishing: 15] [Article Influence: 2.9] [Reference Citation Analysis]
5 Khurshid Q, Mahmoud A, Shahid M, Mohamed A, Shahbaz A. Atypical Hemolytic Uremic Syndrome Associated With Clostridium Difficile Infection. Cureus 2020;12:e9005. [PMID: 32775085 DOI: 10.7759/cureus.9005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Akindolire MA, Ateba CN. Use of pulsed field gel electrophoresis genetic typing for tracing contamination with virulent Escherichia coli O157:H7 in beef-cattle producing farms. Gene Reports 2018;13:59-65. [DOI: 10.1016/j.genrep.2018.08.011] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
7 Canpolat N. Hemolytic uremic syndrome. Turk Pediatri Ars 2015;50:73-82. [PMID: 26265890 DOI: 10.5152/tpa.2015.2297] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
8 Kuroki Y, Mitsuiki K, Nakagawa K, Tsuruya K, Katafuchi R, Hirakata H, Nakano T. Late renal recovery after treatment over 1 year post-onset in an atypical hemolytic uremic syndrome: a case report. BMC Nephrol 2020;21:236. [PMID: 32571244 DOI: 10.1186/s12882-020-01897-4] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Mache CJ, Acham-Roschitz B, Frémeaux-Bacchi V, Kirschfink M, Zipfel PF, Roedl S, Vester U, Ring E. Complement inhibitor eculizumab in atypical hemolytic uremic syndrome. Clin J Am Soc Nephrol 2009;4:1312-6. [PMID: 19556379 DOI: 10.2215/CJN.01090209] [Cited by in Crossref: 113] [Cited by in F6Publishing: 49] [Article Influence: 8.7] [Reference Citation Analysis]
10 Furmańczyk-Zawiska A, Kubiak-Dydo A, Użarowska-Gąska E, Kotlarek-Łysakowska M, Salata K, Kolanowska M, Świerniak M, Gaj P, Leszczyńska B, Daniel M, Jażdżewski K, Durlik M, Wójcicka A. Compound Haplotype Variants in CFH and CD46 Genes Determine Clinical Outcome of Atypical Hemolytic Uremic Syndrome (aHUS)-A Series of Cases from a Single Family. J Pers Med 2021;11:304. [PMID: 33920896 DOI: 10.3390/jpm11040304] [Reference Citation Analysis]
11 Morabito S, Minelli F, Tozzoli R. Integrated Approach for the Diagnosis of Shiga Toxin-Producing Escherichia coli Infections in Humans. Methods Mol Biol 2021;2291:1-17. [PMID: 33704747 DOI: 10.1007/978-1-0716-1339-9_1] [Reference Citation Analysis]
12 Lemaignen A, Ridel C, Hertig A, Rondeau E. [Escherichia coli associated hemolytic and uremic syndrome: what lessons can be learned after the European epidemic of 2011?]. Nephrol Ther 2013;9:129-36. [PMID: 23266201 DOI: 10.1016/j.nephro.2012.10.011] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
13 Watanabe T. Renal complications of seasonal and pandemic influenza A virus infections. Eur J Pediatr 2013;172:15-22. [PMID: 23064728 DOI: 10.1007/s00431-012-1854-x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
14 Sánchez Chinchilla D, Pinto S, Hoppe B, Adragna M, Lopez L, Justa Roldan ML, Peña A, Lopez Trascasa M, Sánchez-Corral P, Rodríguez de Córdoba S. Complement mutations in diacylglycerol kinase-ε-associated atypical hemolytic uremic syndrome. Clin J Am Soc Nephrol 2014;9:1611-9. [PMID: 25135762 DOI: 10.2215/CJN.01640214] [Cited by in Crossref: 51] [Cited by in F6Publishing: 27] [Article Influence: 6.4] [Reference Citation Analysis]
15 Loirat C, Girma JP, Desconclois C, Coppo P, Veyradier A. Thrombotic thrombocytopenic purpura related to severe ADAMTS13 deficiency in children. Pediatr Nephrol 2009;24:19-29. [PMID: 18574602 DOI: 10.1007/s00467-008-0863-5] [Cited by in Crossref: 43] [Cited by in F6Publishing: 30] [Article Influence: 3.1] [Reference Citation Analysis]
16 Loirat C, Noris M, Fremeaux-Bacchi V. Complement and the atypical hemolytic uremic syndrome in children. Pediatr Nephrol 2008;23:1957-72. [PMID: 18594873 DOI: 10.1007/s00467-008-0872-4] [Cited by in Crossref: 135] [Cited by in F6Publishing: 109] [Article Influence: 9.6] [Reference Citation Analysis]
17 Mayer CL, Leibowitz CS, Kurosawa S, Stearns-Kurosawa DJ. Shiga toxins and the pathophysiology of hemolytic uremic syndrome in humans and animals. Toxins (Basel) 2012;4:1261-87. [PMID: 23202315 DOI: 10.3390/toxins4111261] [Cited by in Crossref: 86] [Cited by in F6Publishing: 68] [Article Influence: 8.6] [Reference Citation Analysis]
18 Sasapu A, Cottler-Fox M, Motwani P. Acquired thrombotic thrombocytopenic purpura and atypical hemolytic uremic syndrome successfully treated with eculizumab. Proc (Bayl Univ Med Cent) 2017;30:182-3. [PMID: 28405075 DOI: 10.1080/08998280.2017.11929576] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
19 Liu Y, Tian S, Thaker H, Dong M. Shiga Toxins: An Update on Host Factors and Biomedical Applications. Toxins (Basel) 2021;13:222. [PMID: 33803852 DOI: 10.3390/toxins13030222] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
20 Saland JM, Shneider BL, Bromberg JS, Shi PA, Ward SC, Magid MS, Benchimol C, Seikaly MG, Emre SH, Bresin E, Remuzzi G. Successful split liver-kidney transplant for factor H associated hemolytic uremic syndrome. Clin J Am Soc Nephrol. 2009;4:201-206. [PMID: 19005013 DOI: 10.2215/cjn.02170508] [Cited by in Crossref: 53] [Cited by in F6Publishing: 21] [Article Influence: 3.8] [Reference Citation Analysis]
21 Nguyen TC, Cruz MA, Carcillo JA. Thrombocytopenia-Associated Multiple Organ Failure and Acute Kidney Injury. Crit Care Clin 2015;31:661-74. [PMID: 26410136 DOI: 10.1016/j.ccc.2015.06.004] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 4.1] [Reference Citation Analysis]
22 Patry C, Plotnicki K, Betzen C, Ortiz AP, Pappan KL, Satchell SC, Mathieson PW, Bielaszewska M, Karch H, Tönshoff B, Rafat N. Metabolomic analysis of Shiga toxin 2a-induced injury in conditionally immortalized glomerular endothelial cells. Metabolomics 2019;15:131. [PMID: 31576432 DOI: 10.1007/s11306-019-1594-2] [Reference Citation Analysis]
23 Volokhina E, Westra D, Xue X, Gros P, van de Kar N, van den Heuvel L. Novel C3 mutation p.Lys65Gln in aHUS affects complement factor H binding. Pediatr Nephrol 2012;27:1519-24. [PMID: 22669319 DOI: 10.1007/s00467-012-2183-z] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 2.8] [Reference Citation Analysis]
24 Ballem A, Gonçalves S, Garcia-Meniño I, Flament-Simon SC, Blanco JE, Fernandes C, Saavedra MJ, Pinto C, Oliveira H, Blanco J, Almeida G, Almeida C. Prevalence and serotypes of Shiga toxin-producing Escherichia coli (STEC) in dairy cattle from Northern Portugal. PLoS One 2020;15:e0244713. [PMID: 33382795 DOI: 10.1371/journal.pone.0244713] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Tironi-Farinati C, Geoghegan PA, Cangelosi A, Pinto A, Loidl CF, Goldstein J. A translational murine model of sub-lethal intoxication with Shiga toxin 2 reveals novel ultrastructural findings in the brain striatum. PLoS One 2013;8:e55812. [PMID: 23383285 DOI: 10.1371/journal.pone.0055812] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
26 Psotka MA, Obata F, Kolling GL, Gross LK, Saleem MA, Satchell SC, Mathieson PW, Obrig TG. Shiga toxin 2 targets the murine renal collecting duct epithelium. Infect Immun 2009;77:959-69. [PMID: 19124603 DOI: 10.1128/IAI.00679-08] [Cited by in Crossref: 57] [Cited by in F6Publishing: 36] [Article Influence: 4.4] [Reference Citation Analysis]
27 Long B, Bridwell RE, Manchanda S, Gottlieb M. Evaluation and Management of Thrombotic Thrombocytopenic Purpura in the Emergency Department. J Emerg Med 2021;61:674-82. [PMID: 34518045 DOI: 10.1016/j.jemermed.2021.07.045] [Reference Citation Analysis]
28 Lin CY, Xie J, Freedman SB, McKee RS, Schnadower D, Tarr PI, Finkelstein Y, Desai NM, Lane RD, Bergmann KR, Kaplan RL, Hariharan S, Cruz AT, Cohen DM, Dixon A, Ramgopal S, Powell EC, Kilgar J, Michelson KA, Bitzan M, Yen K, Meckler GD, Plint AC, Balamuth F, Bradin S, Gouin S, Kam AJ, Meltzer JA, Hunley TE, Avva U, Porter R, Fein DM, Louie JP, Tarr GAM; Pediatric Emergency Research Canada (PERC) and Pediatric Emergency Medicine Collaborative Research Committee (PEMCRC) STEC Study Group. Predicting Adverse Outcomes for Shiga Toxin-Producing Escherichia coli Infections in Emergency Departments. J Pediatr 2021;232:200-206.e4. [PMID: 33417918 DOI: 10.1016/j.jpeds.2020.12.077] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Amigo N, Mercado E, Bentancor A, Singh P, Vilte D, Gerhardt E, Zotta E, Ibarra C, Manning SD, Larzábal M, Cataldi A. Clade 8 and Clade 6 Strains of Escherichia coli O157:H7 from Cattle in Argentina have Hypervirulent-Like Phenotypes. PLoS One 2015;10:e0127710. [PMID: 26030198 DOI: 10.1371/journal.pone.0127710] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 4.0] [Reference Citation Analysis]
30 Cañas CA, Vecino MJ, Posso-Osorio I. Atypical Hemolytic Uremic Syndrome in a Patient With Bothrops asper Envenomation. Wilderness Environ Med 2021:S1080-6032(21)00168-X. [PMID: 34740531 DOI: 10.1016/j.wem.2021.08.010] [Reference Citation Analysis]
31 Keenswijk W, Raes A, Vande Walle J. Is eculizumab efficacious in Shigatoxin-associated hemolytic uremic syndrome? A narrative review of current evidence. Eur J Pediatr 2018;177:311-8. [PMID: 29288280 DOI: 10.1007/s00431-017-3077-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
32 Pugh D, O'Sullivan ED, Duthie FA, Masson P, Kavanagh D. Interventions for atypical haemolytic uraemic syndrome. Cochrane Database Syst Rev 2021;3:CD012862. [PMID: 33783815 DOI: 10.1002/14651858.CD012862.pub2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
33 Bowen EE, Hangartner R, Macdougall I. Campylobacter-Associated Hemolytic Uremic Syndrome Associated with Pulmonary-Renal Syndrome. J Gen Intern Med 2016;31:353-6. [PMID: 26001543 DOI: 10.1007/s11606-015-3403-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
34 Ruggenenti P, Remuzzi G. Thrombotic microangiopathy: E. coli O104:H4 German outbreak: a missed opportunity. Nat Rev Nephrol 2012;8:558-60. [PMID: 22945489 DOI: 10.1038/nrneph.2012.194] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
35 Jacquinet S, De Rauw K, Pierard D, Godefroid N, Collard L, Van Hoeck K, Sabbe M. Haemolytic uremic syndrome surveillance in children less than 15 years in Belgium, 2009-2015. Arch Public Health 2018;76:41. [PMID: 30128150 DOI: 10.1186/s13690-018-0289-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
36 Mijatovic D, Blagaic A, Zupan Z. Case Report: Severe form of hemolytic-uremic syndrome with multiple organ failure in a child: a case report. F1000Res 2014;3:79. [PMID: 25075296 DOI: 10.12688/f1000research.2546.2] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
37 Gurjar BS, Manikanta Sriharsha T, Bhasym A, Prabhu S, Puraswani M, Khandelwal P, Saini H, Saini S, Verma AK, Chatterjee P, Guchhait P, Bal V, George A, Rath S, Sahu A, Sharma A, Hari P, Sinha A, Bagga A. Characterization of genetic predisposition and autoantibody profile in atypical haemolytic-uraemic syndrome. Immunology 2018. [PMID: 29485195 DOI: 10.1111/imm.12916] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
38 Kennedy J, Simmonds L, Orme R, Doherty W. An unusual case of Escherichia coli O157:H7 infection with pseudomembranous colitis-like lesions associated with haemolytic-uraemic syndrome and neurological sequelae. BMJ Case Rep 2017;2017:bcr-2016-218586. [PMID: 28630239 DOI: 10.1136/bcr-2016-218586] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
39 Dierkes F, Andriopoulos N, Sucker C, Kuhr K, Hollenbeck M, Hetzel GR, Burst V, Teschner S, Rump LC, Benzing T, Grabensee B, Kurschat CE. Indicators of acute and persistent renal damage in adult thrombotic microangiopathy. PLoS One 2012;7:e30886. [PMID: 22292070 DOI: 10.1371/journal.pone.0030886] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
40 Vaterodt L, Holle J, Hüseman D, Müller D, Thumfart J. Short- and Long-Term Renal Outcome of Hemolytic-Uremic Syndrome in Childhood. Front Pediatr 2018;6:220. [PMID: 30131950 DOI: 10.3389/fped.2018.00220] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
41 Koutroutsos K, Jardine J, Ross L, Papageorghiou A, Stasi R, Banerjee D. A curious case of haemolysis, seizure and acute renal failure associated with pregnancy. J Nephrol 2014;27:345-8. [PMID: 24482089 DOI: 10.1007/s40620-013-0007-2] [Reference Citation Analysis]
42 Schwidder M, Hensel M, Schmidt H. Regulation of nleA in Shiga toxin-producing Escherichia coli O84:H4 strain 4795/97. J Bacteriol 2011;193:832-41. [PMID: 21131485 DOI: 10.1128/JB.00582-10] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
43 Saad AF, Roman J, Wyble A, Pacheco LD. Pregnancy-Associated Atypical Hemolytic-Uremic Syndrome. AJP Rep 2016;6:e125-8. [PMID: 26989566 DOI: 10.1055/s-0036-1579539] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
44 Noris M, Remuzzi G. Complement factor h gene abnormalities in haemolytic uraemic syndrome: from point mutations to hybrid gene. PLoS Med 2006;3:e432. [PMID: 17076562 DOI: 10.1371/journal.pmed.0030432] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
45 Arnold DM, Patriquin CJ, Nazy I. Thrombotic microangiopathies: a general approach to diagnosis and management. CMAJ 2017;189:E153-9. [PMID: 27754896 DOI: 10.1503/cmaj.160142] [Cited by in Crossref: 28] [Cited by in F6Publishing: 18] [Article Influence: 4.7] [Reference Citation Analysis]
46 Scheiring J, Rosales A, Zimmerhackl LB. Clinical practice. Today's understanding of the haemolytic uraemic syndrome. Eur J Pediatr 2010;169:7-13. [PMID: 19707787 DOI: 10.1007/s00431-009-1039-4] [Cited by in Crossref: 86] [Cited by in F6Publishing: 63] [Article Influence: 6.6] [Reference Citation Analysis]
47 Locatelli M, Buelli S, Pezzotta A, Corna D, Perico L, Tomasoni S, Rottoli D, Rizzo P, Conti D, Thurman JM, Remuzzi G, Zoja C, Morigi M. Shiga toxin promotes podocyte injury in experimental hemolytic uremic syndrome via activation of the alternative pathway of complement. J Am Soc Nephrol 2014;25:1786-98. [PMID: 24578132 DOI: 10.1681/ASN.2013050450] [Cited by in Crossref: 34] [Cited by in F6Publishing: 24] [Article Influence: 4.3] [Reference Citation Analysis]
48 Abeles SR, Ly M, Santiago-Rodriguez TM, Pride DT. Effects of Long Term Antibiotic Therapy on Human Oral and Fecal Viromes. PLoS One. 2015;10:e0134941. [PMID: 26309137 DOI: 10.1371/journal.pone.0134941] [Cited by in Crossref: 63] [Cited by in F6Publishing: 57] [Article Influence: 9.0] [Reference Citation Analysis]
49 Milošević B, Stojanović V, Nikolić M, Konstantinidis G, Rudić A. Common variable immunodeficiency complicated with hemolytic uremic syndrome. Ups J Med Sci 2012;117:67-71. [PMID: 22059898 DOI: 10.3109/03009734.2011.635815] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
50 Bonetti V, Mangia CM, Zuza JM, Barcelos MO, Fonseca MM, Nery SP, Carvalhaes JT, Andrade MC. Hemolytic-Uremic Syndrome in Uberlândia, MG, Brazil. ISRN Pediatr 2011;2011:651749. [PMID: 22389782 DOI: 10.5402/2011/651749] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
51 Józsi M, Oppermann M, Lambris JD, Zipfel PF. The C-terminus of complement factor H is essential for host cell protection. Mol Immunol 2007;44:2697-706. [PMID: 17208302 DOI: 10.1016/j.molimm.2006.12.001] [Cited by in Crossref: 73] [Cited by in F6Publishing: 75] [Article Influence: 4.9] [Reference Citation Analysis]
52 Simpson HD, Johnson E, Britton J, Braksick S. Alternating hemiparesis in the context of hemolytic uremic syndrome and COVID-19 positivity. Epilepsy Behav Rep 2021;16:100468. [PMID: 34250459 DOI: 10.1016/j.ebr.2021.100468] [Reference Citation Analysis]
53 Amigo N, Zhang Q, Amadio A, Zhang Q, Silva WM, Cui B, Chen Z, Larzabal M, Bei J, Cataldi A. Overexpressed Proteins in Hypervirulent Clade 8 and Clade 6 Strains of Escherichia coli O157:H7 Compared to E. coli O157:H7 EDL933 Clade 3 Strain. PLoS One 2016;11:e0166883. [PMID: 27880834 DOI: 10.1371/journal.pone.0166883] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
54 Rafiq A, Tariq H, Abbas N, Shenoy R. Atypical hemolytic-uremic syndrome: a case report and literature review. Am J Case Rep 2015;16:109-14. [PMID: 25708146 DOI: 10.12659/AJCR.892907] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
55 Zewde N, Gorham RD Jr, Dorado A, Morikis D. Quantitative Modeling of the Alternative Pathway of the Complement System. PLoS One 2016;11:e0152337. [PMID: 27031863 DOI: 10.1371/journal.pone.0152337] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 4.2] [Reference Citation Analysis]
56 Davin JC, van de Kar NC. Advances and challenges in the management of complement-mediated thrombotic microangiopathies. Ther Adv Hematol 2015;6:171-85. [PMID: 26288712 DOI: 10.1177/2040620715577613] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
57 Segal MS, Baylis C, Johnson RJ. Endothelial health and diversity in the kidney. J Am Soc Nephrol 2006;17:323-4. [PMID: 16434502 DOI: 10.1681/ASN.2005121296] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
58 Vaughn JL, Moore JM, Cataland SR. Acute Systolic Heart Failure Associated with Complement-Mediated Hemolytic Uremic Syndrome. Case Rep Hematol 2015;2015:327980. [PMID: 26557394 DOI: 10.1155/2015/327980] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
59 Loirat C, Fremeaux-bacchi V. Recurrence of haemolytic uraemic syndrome after renal transplantation. Current Opinion in Organ Transplantation 2007;12:496-502. [DOI: 10.1097/mot.0b013e3282ef3d64] [Reference Citation Analysis]
60 Brigotti M. The interactions of human neutrophils with shiga toxins and related plant toxins: danger or safety? Toxins (Basel) 2012;4:157-90. [PMID: 22741061 DOI: 10.3390/toxins4030157] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.1] [Reference Citation Analysis]
61 Pandey Y, Atwal D, Sasapu A. Diarrhea-associated Hemolytic Uremic Syndrome in Adults: Two Case Reports and Review of the Literature. Cureus 2019;11:e4435. [PMID: 31245222 DOI: 10.7759/cureus.4435] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
62 Goldstein J, Nuñez-Goluboay K, Pinto A. Therapeutic Strategies to Protect the Central Nervous System against Shiga Toxin from Enterohemorrhagic Escherichia coli. Curr Neuropharmacol 2021;19:24-44. [PMID: 32077828 DOI: 10.2174/1570159X18666200220143001] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
63 Cornfield DN. Shifting the Paradigm in Hemolytic Uremic Syndrome. Pediatrics 2016;137. [PMID: 26644489 DOI: 10.1542/peds.2015-3524] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
64 Keir LS, Marks SD, Kim JJ. Shigatoxin-associated hemolytic uremic syndrome: current molecular mechanisms and future therapies. Drug Des Devel Ther 2012;6:195-208. [PMID: 22888220 DOI: 10.2147/DDDT.S25757] [Cited by in Crossref: 4] [Cited by in F6Publishing: 12] [Article Influence: 0.4] [Reference Citation Analysis]
65 Kim YK, Cho MH, Hyun HS, Park E, Ha IS, Cheong HI, Kang HG. Acute kidney injury associated with Yersinia pseudotuberculosis infection: Forgotten but not gone. Kidney Res Clin Pract 2019;38:347-55. [PMID: 31434167 DOI: 10.23876/j.krcp.19.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
66 Krogvold L, Henrichsen T, Bjerre A, Brackman D, Dollner H, Gudmundsdottir H, Syversen G, Næss PA, Bangstad HJ. Clinical aspects of a nationwide epidemic of severe haemolytic uremic syndrome (HUS) in children. Scand J Trauma Resusc Emerg Med 2011;19:44. [PMID: 21798000 DOI: 10.1186/1757-7241-19-44] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
67 Matsukuma E, Imamura A, Iwata Y, Takeuchi T, Yoshida Y, Fujimura Y, Fan X, Miyata T, Kuwahara T. Postoperative atypical hemolytic uremic syndrome associated with complement c3 mutation. Case Rep Nephrol 2014;2014:784943. [PMID: 25431709 DOI: 10.1155/2014/784943] [Cited by in Crossref: 3] [Article Influence: 0.4] [Reference Citation Analysis]
68 Zhang K, Lu Y, Harley KT, Tran MH. Atypical Hemolytic Uremic Syndrome: A Brief Review. Hematol Rep 2017;9:7053. [PMID: 28626544 DOI: 10.4081/hr.2017.7053] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 5.2] [Reference Citation Analysis]
69 Huzmeli C, Candan F, Seker A, Yildiz E, Terzi H, Kayatas M. C3 mesangial proliferative glomerulonephritis initially presenting with atypical hemolytic uremic syndrome: a case report. J Med Case Rep 2016;10:206. [PMID: 27460033 DOI: 10.1186/s13256-016-0992-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
70 Watanabe T. Kidney and urinary tract involvement in kawasaki disease. Int J Pediatr. 2013;2013:831834. [PMID: 24288547 DOI: 10.1155/2013/831834] [Cited by in Crossref: 29] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
71 Kavanagh D, Goodship T. Genetics and complement in atypical HUS. Pediatr Nephrol 2010;25:2431-42. [PMID: 20526633 DOI: 10.1007/s00467-010-1555-5] [Cited by in Crossref: 117] [Cited by in F6Publishing: 98] [Article Influence: 9.8] [Reference Citation Analysis]
72 Wadehra A, Alkassis S. Atypical Hemolytic Uremic Syndrome in the Setting of Acute Clostridium difficile Colitis. Cureus 2021;13:e13244. [PMID: 33728192 DOI: 10.7759/cureus.13244] [Reference Citation Analysis]
73 Herrmann J, Wenzel U, Galler S, Schoennagel BP, Busch JD, Tozakidou M, Petersen KU, Joekel M, Bannas P, Yamamura J, Groth M, Adam G, Habermann CR. Diffusion-weighted imaging of the kidneys in haemolytic uraemic syndrome. Eur Radiol 2017;27:4591-601. [PMID: 28500363 DOI: 10.1007/s00330-017-4848-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
74 Yan K, Desai K, Gullapalli L, Druyts E, Balijepalli C. Epidemiology of Atypical Hemolytic Uremic Syndrome: A Systematic Literature Review. Clin Epidemiol. 2020;12:295-305. [PMID: 32210633 DOI: 10.2147/clep.s245642] [Cited by in Crossref: 16] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
75 Yenerel MN. Atypical Hemolytic Uremic Syndrome: Differential Diagnosis from TTP/HUS and Management. Turk J Haematol 2014;31:216-25. [PMID: 25319590 DOI: 10.4274/tjh.2013.0374] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
76 Abbas F, El Kossi M, Kim JJ, Sharma A, Halawa A. Thrombotic microangiopathy after renal transplantation: Current insights in de novo and recurrent disease. World J Transplantation 2018; 8(5): 122-141 [PMID: 30211021 DOI: 10.5500/wjt.v8.i5.122] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 8] [Article Influence: 4.8] [Reference Citation Analysis]
77 Lee JW, Won NH, Cho E, Kim MG, Jo SK, Cho WY, Kim HK. Postoperative hemolytic uremic syndrome with renal cortical necrosis following laparoscopic hemicolectomy. Ren Fail 2013;35:725-8. [PMID: 23560430 DOI: 10.3109/0886022X.2013.780978] [Cited by in Crossref: 5] [Article Influence: 0.6] [Reference Citation Analysis]
78 Almalki AH, Sadagah LF, Qureshi M, Maghrabi H, Algain A, Alsaeed A. Atypical hemolytic-uremic syndrome due to complement factor I mutation. World J Nephrol 2017; 6(6): 243-250 [PMID: 29226095 DOI: 10.5527/wjn.v6.i6.243] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
79 Sexton DJ, Reule S, Solid CA, Chen SC, Collins AJ, Foley RN. End-stage renal disease from hemolytic uremic syndrome in the United States, 1995-2010. Hemodial Int 2015;19:521-30. [PMID: 25689876 DOI: 10.1111/hdi.12281] [Reference Citation Analysis]
80 Capone V, Mancuso MC, Tamburini G, Montini G, Ardissino G. Hemoglobinuria for the early identification of STEC-HUS in high-risk children: data from the ItalKid-HUS Network. Eur J Pediatr 2021;180:2791-5. [PMID: 33759020 DOI: 10.1007/s00431-021-04016-z] [Reference Citation Analysis]
81 Gray JM, Ameduri RK. Tacrolimus-associated hemolytic uremic syndrome in a pediatric heart transplant recipient. Pediatr Transplant 2016;20:866-7. [PMID: 27371345 DOI: 10.1111/petr.12744] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
82 Reid VL, Mullan A, Erwig LP. Rapid recovery of membrane cofactor protein (MCP; CD46) associated atypical haemolytic uraemic syndrome with plasma exchange. BMJ Case Rep 2013;2013:bcr2013200980. [PMID: 24005975 DOI: 10.1136/bcr-2013-200980] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
83 Da Silva WM, Bei J, Amigo N, Valacco MP, Amadio A, Zhang Q, Wu X, Yu T, Larzabal M, Chen Z, Cataldi A. Quantification of enterohemorrhagic Escherichia coli O157:H7 protein abundance by high-throughput proteome. PLoS One 2018;13:e0208520. [PMID: 30596662 DOI: 10.1371/journal.pone.0208520] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
84 Gonzalo-Gil E, García-Herrero C, Toldos O, Usategui A, Criado G, Pérez-Yagüe S, Barber DF, Pablos JL, Galindo M. Microthrombotic Renal Vascular Lesions Are Associated to Increased Renal Inflammatory Infiltration in Murine Lupus Nephritis. Front Immunol 2018;9:1948. [PMID: 30210500 DOI: 10.3389/fimmu.2018.01948] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
85 Barbour T, Johnson S, Cohney S, Hughes P. Thrombotic microangiopathy and associated renal disorders. Nephrol Dial Transplant. 2012;27:2673-2685. [PMID: 22802583 DOI: 10.1093/ndt/gfs279] [Cited by in Crossref: 121] [Cited by in F6Publishing: 93] [Article Influence: 12.1] [Reference Citation Analysis]
86 Bianchi L, Gaiani F, Vincenzi F, Kayali S, Di Mario F, Leandro G, De' Angelis GL, Ruberto C. Hemolytic uremic syndrome: differential diagnosis with the onset of inflammatory bowel diseases. Acta Biomed 2018;89:153-7. [PMID: 30561409 DOI: 10.23750/abm.v89i9-S.7911] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
87 Pundzienė B, Dobilienė D, Čerkauskienė R, Mitkienė R, Medzevičienė A, Darškuvienė E, Jankauskienė A. Long-term follow-up of children with typical hemolytic uremic syndrome. Medicina (Kaunas) 2015;51:146-51. [PMID: 28705476 DOI: 10.1016/j.medici.2015.06.004] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
88 Beckham KS, Connolly JP, Ritchie JM, Wang D, Gawthorne JA, Tahoun A, Gally DL, Burgess K, Burchmore RJ, Smith BO, Beatson SA, Byron O, Wolfe AJ, Douce GR, Roe AJ. The metabolic enzyme AdhE controls the virulence of Escherichia coli O157:H7. Mol Microbiol 2014;93:199-211. [PMID: 24846743 DOI: 10.1111/mmi.12651] [Cited by in Crossref: 40] [Cited by in F6Publishing: 34] [Article Influence: 5.0] [Reference Citation Analysis]
89 Desch K, Motto D. ADAMTS13 and VWF: not just for TTP anymore? Blood 2005;106:4024-4024. [DOI: 10.1182/blood-2005-09-3895] [Reference Citation Analysis]
90 Walker CL, Applegate JA, Black RE. Haemolytic-uraemic syndrome as a sequela of diarrhoeal disease. J Health Popul Nutr 2012;30:257-61. [PMID: 23082627 DOI: 10.3329/jhpn.v30i3.12288] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
91 Noris M, Remuzzi G. Translational mini-review series on complement factor H: therapies of renal diseases associated with complement factor H abnormalities: atypical haemolytic uraemic syndrome and membranoproliferative glomerulonephritis. Clin Exp Immunol 2008;151:199-209. [PMID: 18070148 DOI: 10.1111/j.1365-2249.2007.03558.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
92 Motto D. Endothelial cells and thrombotic microangiopathy. Semin Nephrol 2012;32:208-14. [PMID: 22617770 DOI: 10.1016/j.semnephrol.2012.02.007] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
93 Yamaji T, Nishikawa K, Hanada K. Transmembrane BAX inhibitor motif containing (TMBIM) family proteins perturbs a trans-Golgi network enzyme, Gb3 synthase, and reduces Gb3 biosynthesis. J Biol Chem 2010;285:35505-18. [PMID: 20837469 DOI: 10.1074/jbc.M110.154229] [Cited by in Crossref: 40] [Cited by in F6Publishing: 25] [Article Influence: 3.3] [Reference Citation Analysis]
94 de Córdoba SR, de Jorge EG. Translational mini-review series on complement factor H: genetics and disease associations of human complement factor H. Clin Exp Immunol 2008;151:1-13. [PMID: 18081690 DOI: 10.1111/j.1365-2249.2007.03552.x] [Cited by in Crossref: 192] [Cited by in F6Publishing: 184] [Article Influence: 13.7] [Reference Citation Analysis]
95 Martínez-Barricarte R, Goicoechea de Jorge E, Montes T, Layana AG, Rodríguez de Córdoba S. Lack of association between polymorphisms in C4b-binding protein and atypical haemolytic uraemic syndrome in the Spanish population. Clin Exp Immunol 2009;155:59-64. [PMID: 19076829 DOI: 10.1111/j.1365-2249.2008.03798.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
96 Silecchia V, D'Onofrio G, Valerio E, Rubin G, Vidal E, Murer L. Influenza-associated hemolytic uremic syndrome: The pathogenic role of the virus. Clin Nephrol Case Stud 2021;9:45-8. [PMID: 33884256 DOI: 10.5414/CNCS110219] [Reference Citation Analysis]
97 Osugi Y, Ishiguro K, Kobayashi D. Association Between Antidiarrheal Drug Prescription and Return Visits Among Adult Patients With Acute Diarrhea. Cureus 2021;13:e18807. [PMID: 34796079 DOI: 10.7759/cureus.18807] [Reference Citation Analysis]
98 Westra D, Dorresteijn EM, Beishuizen A, van den Heuvel LP, Brons PP, van de Kar NC. The challenge of managing hemophilia A and STEC-induced hemolytic uremic syndrome. Pediatr Nephrol 2013;28:349-52. [PMID: 23001024 DOI: 10.1007/s00467-012-2312-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
99 Trachtman H, Austin C, Lewinski M, Stahl RA. Renal and neurological involvement in typical Shiga toxin-associated HUS. Nat Rev Nephrol 2012;8:658-69. [PMID: 22986362 DOI: 10.1038/nrneph.2012.196] [Cited by in Crossref: 129] [Cited by in F6Publishing: 113] [Article Influence: 12.9] [Reference Citation Analysis]
100 Renner B, Klawitter J, Goldberg R, McCullough JW, Ferreira VP, Cooper JE, Christians U, Thurman JM. Cyclosporine induces endothelial cell release of complement-activating microparticles. J Am Soc Nephrol. 2013;24:1849-1862. [PMID: 24092930 DOI: 10.1681/asn.2012111064] [Cited by in Crossref: 48] [Cited by in F6Publishing: 26] [Article Influence: 5.3] [Reference Citation Analysis]
101 Brigotti M, Carnicelli D, Ravanelli E, Vara AG, Martinelli C, Alfieri RR, Petronini PG, Sestili P. Molecular damage and induction of proinflammatory cytokines in human endothelial cells exposed to Shiga toxin 1, Shiga toxin 2, and alpha-sarcin. Infect Immun 2007;75:2201-7. [PMID: 17296757 DOI: 10.1128/IAI.01707-06] [Cited by in Crossref: 33] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
102 Woodman CJ, Min-venditti AA, Woosnam KM, Brightsmith DJ. Water quality for guest health at remote Amazon ecotourism lodges. Tourism Management 2019;72:202-8. [DOI: 10.1016/j.tourman.2018.11.014] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
103 Palanca D, Garcia-Cazorla A, Ortiz J, Jou C, Cusí V, Suñol M, Toll T, Perez B, Ormazabal A, Fowler B, Artuch R. cblE-Type Homocystinuria Presenting with Features of Haemolytic-Uremic Syndrome in the Newborn Period. JIMD Rep 2013;8:57-62. [PMID: 23430521 DOI: 10.1007/8904_2012_161] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
104 Rivero MA, Passucci JA, Rodríguez EM, Parma AE. Seasonal variation of HUS occurrence and VTEC infection in children with acute diarrhoea from Argentina. Eur J Clin Microbiol Infect Dis 2012;31:1131-5. [PMID: 21938536 DOI: 10.1007/s10096-011-1418-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
105 Giordano M, Baldassarre ME, Palmieri V, Torres DD, Carbone V, Santangelo L, Gentile F, Panza R, Di Mauro F, Capozza M, Di Mauro A, Laforgia N. Management of STEC Gastroenteritis: Is There a Role for Probiotics? Int J Environ Res Public Health 2019;16:E1649. [PMID: 31083597 DOI: 10.3390/ijerph16091649] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
106 Caillaud C, Zaloszyc A, Licht C, Pichault V, Frémeaux-Bacchi V, Fischbach M. CFH gene mutation in a case of Shiga toxin-associated hemolytic uremic syndrome (STEC-HUS). Pediatr Nephrol 2016;31:157-61. [PMID: 26399238 DOI: 10.1007/s00467-015-3207-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.9] [Reference Citation Analysis]
107 Nicolon C, Broustal E. [Acute renal failure after dengue virus infection: A pediatric case report]. Arch Pediatr 2016;23:53-5. [PMID: 26563725 DOI: 10.1016/j.arcped.2015.09.021] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
108 Jandhyala DM, Vanguri V, Boll EJ, Lai Y, McCormick BA, Leong JM. Shiga toxin-producing Escherichia coli O104:H4: an emerging pathogen with enhanced virulence. Infect Dis Clin North Am 2013;27:631-49. [PMID: 24011834 DOI: 10.1016/j.idc.2013.05.002] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
109 McCluskey AJ, Bolewska-Pedyczak E, Jarvik N, Chen G, Sidhu SS, Gariépy J. Charged and hydrophobic surfaces on the a chain of shiga-like toxin 1 recognize the C-terminal domain of ribosomal stalk proteins. PLoS One 2012;7:e31191. [PMID: 22355345 DOI: 10.1371/journal.pone.0031191] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 2.8] [Reference Citation Analysis]
110 Sundström K. Cost of Illness for Five Major Foodborne Illnesses and Sequelae in Sweden. Appl Health Econ Health Policy 2018;16:243-57. [PMID: 29313242 DOI: 10.1007/s40258-017-0369-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 3.7] [Reference Citation Analysis]
111 Mounier S, Gavotto A, Tenenbaum J, Meyer P, Fila M, Baleine J. Hemolytic uremic syndrome related to Shiga-like toxin-producing Escherichia coli with encephalitis hiding a human herpesvirus-6 infection: a case report. J Med Case Rep 2021;15:300. [PMID: 34034812 DOI: 10.1186/s13256-021-02873-8] [Reference Citation Analysis]
112 Allen U, Licht C. Pandemic H1N1 influenza A infection and (atypical) HUS--more than just another trigger? Pediatr Nephrol 2011;26:3-5. [PMID: 21057815 DOI: 10.1007/s00467-010-1690-z] [Cited by in Crossref: 30] [Cited by in F6Publishing: 22] [Article Influence: 2.5] [Reference Citation Analysis]
113 Zoja C, Buelli S, Morigi M. Shiga toxin triggers endothelial and podocyte injury: the role of complement activation. Pediatr Nephrol 2019;34:379-88. [PMID: 29214442 DOI: 10.1007/s00467-017-3850-x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 3.4] [Reference Citation Analysis]
114 Hua Y, Chromek M, Frykman A, Jernberg C, Georgieva V, Hansson S, Zhang J, Marits AK, Wan C, Matussek A, Bai X. Whole-genome characterization of hemolytic uremic syndrome-causing Shiga toxin-producing Escherichia coli in Sweden. Virulence 2021;12:1296-305. [PMID: 33939581 DOI: 10.1080/21505594.2021.1922010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
115 Thomson N, Ulrickson M. Maintenance eculizumab dose adjustment in the treatment of atypical hemolytic uremic syndrome: a case report and review of the literature. Clin Case Rep 2016;4:773-6. [PMID: 27525082 DOI: 10.1002/ccr3.628] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
116 Liszewski MK, Leung MK, Schraml B, Goodship TH, Atkinson JP. Modeling how CD46 deficiency predisposes to atypical hemolytic uremic syndrome. Mol Immunol 2007;44:1559-68. [PMID: 17027083 DOI: 10.1016/j.molimm.2006.08.024] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.3] [Reference Citation Analysis]
117 Martinez-Barricarte R, Pianetti G, Gautard R, Misselwitz J, Strain L, Fremeaux-Bacchi V, Skerka C, Zipfel PF, Goodship T, Noris M, Remuzzi G, de Cordoba SR; European Working Party on the Genetics of HUS. The complement factor H R1210C mutation is associated with atypical hemolytic uremic syndrome. J Am Soc Nephrol 2008;19:639-46. [PMID: 18235085 DOI: 10.1681/ASN.2007080923] [Cited by in Crossref: 67] [Cited by in F6Publishing: 31] [Article Influence: 4.8] [Reference Citation Analysis]
118 Zipfel PF, Skerka C. Complement regulators and inhibitory proteins. Nat Rev Immunol. 2009;9:729-740. [PMID: 19730437 DOI: 10.1038/nri2620] [Cited by in Crossref: 780] [Cited by in F6Publishing: 720] [Article Influence: 60.0] [Reference Citation Analysis]
119 Cho H. Complement regulation: physiology and disease relevance. Korean J Pediatr 2015;58:239-44. [PMID: 26300937 DOI: 10.3345/kjp.2015.58.7.239] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
120 Boyer O, Niaudet P. Hemolytic uremic syndrome: new developments in pathogenesis and treatment. Int J Nephrol 2011;2011:908407. [PMID: 21876803 DOI: 10.4061/2011/908407] [Cited by in Crossref: 31] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
121 Alrahmani L, Willrich MAV. The Complement Alternative Pathway and Preeclampsia. Curr Hypertens Rep 2018;20:40. [PMID: 29717384 DOI: 10.1007/s11906-018-0836-4] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 4.8] [Reference Citation Analysis]
122 Buelli S, Zoja C, Remuzzi G, Morigi M. Complement Activation Contributes to the Pathophysiology of Shiga Toxin-Associated Hemolytic Uremic Syndrome. Microorganisms 2019;7:E15. [PMID: 30634669 DOI: 10.3390/microorganisms7010015] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
123 Hui C, Kern R, Wojciechowski D, Kukreja J, Golden JA, Hays SR, Singer JP. Belatacept for Maintenance Immunosuppression in Lung Transplantation. J Investig Med High Impact Case Rep 2014;2:2324709614546866. [PMID: 26425619 DOI: 10.1177/2324709614546866] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
124 Provaznikova D, Rittich S, Malina M, Seeman T, Marinov I, Riedl M, Hrachovinova I. Manifestation of atypical hemolytic uremic syndrome caused by novel mutations in MCP. Pediatr Nephrol. 2012;27:73-81. [PMID: 21706448 DOI: 10.1007/s00467-011-1943-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
125 Piras R, Iatropoulos P, Bresin E, Todeschini M, Gastoldi S, Valoti E, Alberti M, Mele C, Galbusera M, Cuccarolo P, Benigni A, Remuzzi G, Noris M. Molecular Studies and an ex vivo Complement Assay on Endothelium Highlight the Genetic Complexity of Atypical Hemolytic Uremic Syndrome: The Case of a Pedigree With a Null CD46 Variant. Front Med (Lausanne) 2020;7:579418. [PMID: 33224962 DOI: 10.3389/fmed.2020.579418] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
126 Pacheco AR, Sperandio V. Shiga toxin in enterohemorrhagic E.coli: regulation and novel anti-virulence strategies. Front Cell Infect Microbiol 2012;2:81. [PMID: 22919672 DOI: 10.3389/fcimb.2012.00081] [Cited by in Crossref: 73] [Cited by in F6Publishing: 67] [Article Influence: 7.3] [Reference Citation Analysis]
127 Delvaeye M, Noris M, De Vriese A, Esmon CT, Esmon NL, Ferrell G, Del-Favero J, Plaisance S, Claes B, Lambrechts D. Thrombomodulin mutations in atypical hemolytic-uremic syndrome. N Engl J Med. 2009;361:345-357. [PMID: 19625716 DOI: 10.1056/nejmoa0810739] [Cited by in Crossref: 368] [Cited by in F6Publishing: 153] [Article Influence: 28.3] [Reference Citation Analysis]
128 Loirat C, Frémeaux-Bacchi V. Atypical hemolytic uremic syndrome. Orphanet J Rare Dis 2011;6:60. [PMID: 21902819 DOI: 10.1186/1750-1172-6-60] [Cited by in Crossref: 375] [Cited by in F6Publishing: 304] [Article Influence: 34.1] [Reference Citation Analysis]